BRCA1 or BRCA2 germline mutations reportedly increase the relative risk of pancreatic cancer by 2.26-fold (1.26−4.06) and 3.51-fold (1.87−6.58), respectively [36,37]. This evidence concerns the gene BRCA2 and pancreatic neoplasm.